Cargando…

Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib

Among the noteworthy recent stories in the management and prevention of atherosclerotic cardiovascular disease (CVD) is the saga of the development of pharmacological inhibitors of cholesteryl ester transfer protein (CETP). Inhibiting CETP significantly raises plasma concentrations of high-density l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldberg, Alyse S, Hegele, Robert A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460676/ https://www.ncbi.nlm.nih.gov/pubmed/23055695 http://dx.doi.org/10.2147/DDDT.S34976

Ejemplares similares

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib
por: Miyares, Marta A, et al.
Publicado: (2012)

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
por: Chapman, M. John, et al.
Publicado: (2010)

Cholesteryl Ester Transfer Protein Inhibitors in the Treatment of Dyslipidemia: A Systematic Review and Meta-Analysis
por: Li, Chuanwei, et al.
Publicado: (2013)

Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
por: Zhang, Meng, et al.
Publicado: (2017)

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
por: Mabuchi, Hiroshi, et al.
Publicado: (2014)

Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases
por: Shinkai, Hisashi
Publicado: (2012)

Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors
por: Li, Wen-Yan, et al.
Publicado: (2012)

Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors
por: Wang, Ziyun, et al.
Publicado: (2017)

Cholesteryl Ester Transfer Protein Gene Polymorphisms and Longevity Syndrome
por: Kolovou, Genovefa, et al.
Publicado: (2010)

Structure-based mechanism and inhibition of cholesteryl ester transfer protein
por: Xue, Han, et al.
Publicado: (2023)

Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib
por: Black, Donald M., et al.
Publicado: (2018)

Cholesteryl Ester Transfer Protein Gene and Effectiveness of Lipid Lowering of Atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2010)

Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?
por: Miller, Norman E.
Publicado: (2015)

REVEAL Study: Reveals the Limitations of Cholesteryl Ester Transfer Protein Inhibition
por: Pareek, Anil, et al.
Publicado: (2018)

The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain
por: Oestereich, Felix, et al.
Publicado: (2022)

Design, Synthesis, and Biological Evaluation of Benzylamino-Methanone Based Cholesteryl Ester Transfer Protein Inhibitors
por: Sheikha, Ghassan Abu, et al.
Publicado: (2010)

Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia
por: Poliakova, Tetiana, et al.
Publicado: (2023)

Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
por: Schmidt, Amand F., et al.
Publicado: (2021)

Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
por: Duwensee, Kristina, et al.
Publicado: (2011)

The effect of cholesteryl ester transfer protein on pancreatic beta cell dysfunction in mice
por: Guo, Wen, et al.
Publicado: (2016)

Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein
por: Ji, Ailing, et al.
Publicado: (2023)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

CoMFA, CoMSIA and Eigenvalue Analysis on Dibenzodioxepinone and Dibenzodioxocinone Derivatives as Cholesteryl Ester Transfer Protein Inhibitors
por: Xiong, Xu-qiong, et al.
Publicado: (2008)

Design, Synthesis and Biological Evaluation of N,N-Substituted Amine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors
por: Wang, Xinran, et al.
Publicado: (2017)

How cholesteryl ester transfer protein can also be a potential triglyceride transporter
por: Chirasani, Venkat R., et al.
Publicado: (2017)

Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition
por: Kettunen, Johannes, et al.
Publicado: (2019)

Elevated cholesteryl ester transfer and phospholipid transfer proteins aggravated psoriasis in imiquimod-induced mouse models
por: Chen, Jun, et al.
Publicado: (2022)

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels
por: Nelson, Adam J., et al.
Publicado: (2022)

Impact of drug distribution into adipose on tissue function: The cholesteryl ester transfer protein (CETP) inhibitor anacetrapib as a test case
por: Johns, Douglas G., et al.
Publicado: (2019)

Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP)
por: Choi, Suein, et al.
Publicado: (2019)

Lipid Exchange Mechanism of the Cholesteryl Ester Transfer Protein Clarified by Atomistic and Coarse-grained Simulations
por: Koivuniemi, Artturi, et al.
Publicado: (2012)

How Anacetrapib Inhibits the Activity of the Cholesteryl Ester Transfer Protein? Perspective through Atomistic Simulations
por: Äijänen, Tarja, et al.
Publicado: (2014)

Meta-analysis of Cholesteryl Ester Transfer Protein TaqIB Polymorphism and Risk of Myocardial Infarction
por: Cao, Min, et al.
Publicado: (2014)

Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week
por: Armitage, Jane, et al.
Publicado: (2019)

Correction: Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition
por: Kettunen, Johannes, et al.
Publicado: (2020)

Cholesteryl Ester Transfer Protein Impairs Triglyceride Clearance via Androgen Receptor in Male Mice
por: Palmisano, Brian T., et al.
Publicado: (2020)

Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice
por: Dusuel, Aloïs, et al.
Publicado: (2020)

Fluorescent Sterols and Cholesteryl Esters as Probes for Intracellular Cholesterol Transport
por: Solanko, Katarzyna A., et al.
Publicado: (2016)

Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults
por: Suico, Jeffrey G, et al.
Publicado: (2014)

Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_irlv5ljbmpbfdgmp26e2gj49jo